Effects of low and high doses of fosinopril on the structure and function of resistance arteries.

It has been suggested that angiotensin-converting enzyme inhibitors may induce a significant regression of cardiovascular hypertrophy not only through blood pressure reduction but also as a possible consequence of growth factor inhibition. The aim of this study was to evaluate the effects of the angiotensin-converting enzyme inhibitor fosinopril, given either at a hypotensive high dose or a nonhypotensive low dose, on structural and functional alterations of mesenteric resistance arteries and on cardiac mass in spontaneously hypertensive rats (SHR) and control Wistar-Kyoto rats. Fosinopril was administered in the drinking water from 6 to 12 weeks of age. Rats were killed at 12 weeks, and the ratio of heart weight to body weight was measured. Mesenteric arterioles were dissected and mounted on a micromyograph (Mulvany's technique). Vascular morphology (media-lumen ratio, media thickness) and endothelial function (response to acetylcholine) were then assessed. During the 6 weeks of treatment, systolic pressure in SHR treated with high-dose fosinopril was significantly lower compared with that in untreated SHR, whereas no difference was observed with low-dose fosinopril. In SHR treated with both high-dose and low-dose fosinopril, a statistically significant reduction of vascular structural alterations, in terms of both media-lumen ratio and media thickness, was observed. The ratio of heart weight to body weight was reduced only in SHR treated with high-dose fosinopril. An improvement in the endothelium-dependent relaxation to acetylcholine was observed in SHR treated with high-dose fosinopril compared with untreated SHR, whereas in SHR treated with low-dose fosinopril no improvement in endothelial function was detected.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  E. Porteri,et al.  Delayed development of hypertension after short-term nitrendipine treatment. , 1994, Hypertension.

[2]  G. Gibbons,et al.  The emerging concept of vascular remodeling. , 1994, The New England journal of medicine.

[3]  M. Mulvany,et al.  Dose-dependent effects of perindopril on blood pressure and small-artery structure. , 1994, Hypertension.

[4]  T. Lüscher,et al.  Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. , 1994, Circulation.

[5]  T. Unger,et al.  Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. , 1994, Hypertension.

[6]  E. Porteri,et al.  Vascular structural and functional alterations before and after the development of hypertension in SHR. , 1994, American journal of hypertension.

[7]  E. Schiffrin,et al.  Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. , 1994, Hypertension.

[8]  E. Porteri,et al.  Early treatment with nitrendipine may prevent endothelial dysfunction in mesenteric small arteries of spontaneously hypertensive rats , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[9]  T. Unger,et al.  Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate. , 1993, Hypertension.

[10]  J. N. Wu,et al.  Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. , 1993, Hypertension.

[11]  E. Jackson,et al.  Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. , 1993, Hypertension.

[12]  W. Linz,et al.  Role of Bradykinin in the Cardiac Effects of Angiotensin‐Converting Enzyme Inhibitors , 1992, Journal of cardiovascular pharmacology.

[13]  T. Lüscher.  Heterogeneity of endothelial dysfunction in hypertension. , 1992, European heart journal.

[14]  T. Unger,et al.  Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[15]  M. Mulvany.  The development and regression of vascular hypertrophy. , 1992, Journal of cardiovascular pharmacology.

[16]  G. Gibbons,et al.  Endothelium and Growth Factors in Vascular Remodeling of Hypertension , 1991, Hypertension.

[17]  P. Vanhoutte,et al.  Effects of the Converting Enzyme Inhibitor Cilazaprilat on Endothelium‐Dependent Responses , 1991, Hypertension.

[18]  H. Baumgartner,et al.  Endothelial Dysfunction and Subendothelial Monocyte Macrophages in Hypertension: Effect of Angiotensin Converting Enzyme Inhibition , 1991, Hypertension.

[19]  M. Mulvany,et al.  No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. , 1991, Journal of hypertension.

[20]  M. Mulvany,et al.  Angiotensin II Causes Vascular Hypertrophy in Part by a Non‐pressor Mechanism , 1991, Hypertension.

[21]  P. Kerth,et al.  Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels. , 1991, American journal of hypertension.

[22]  C. Triggle,et al.  Prevention of Hypertension and Vascular Changes by Captopril Treatment , 1991, Hypertension.

[23]  K. Duchin.  Clinical Pharmacology of Fosinopril , 1991 .

[24]  D. Ganten,et al.  Angiotensin and cell growth: a link to cardiovascular hypertrophy? , 1991, Journal of hypertension.

[25]  P. Korner,et al.  Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. , 1991, Journal of Cardiovascular Pharmacology.

[26]  G. Gibbons.  Angiotensin‐Converting Enzyme Inhibition and Vascular Structure in Hypertension , 1991, Journal of cardiovascular pharmacology.

[27]  S. Harrap,et al.  Brief Angiotensin Converting Enzyme Inhibitor Treatment in Young Spontaneously Hypertensive Rats Reduces Blood Pressure Long‐term , 1990, Hypertension.

[28]  M. Adams,et al.  Enalapril Can Prevent Vascular Amplifier Development in Spontaneously Hypertensive Rats , 1990, Hypertension.

[29]  K. Baker,et al.  Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. , 1990, The American journal of physiology.

[30]  A. Quyyumi,et al.  Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. , 1990, The New England journal of medicine.

[31]  J. Clozel,et al.  Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats. , 1989, The American journal of medicine.

[32]  M. Mulvany,et al.  Development of blood pressure in spontaneously hypertensive rats after withdrawal of long‐term treatment related to vascular structure , 1989, Journal of hypertension.

[33]  D. Ganten,et al.  Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. , 1989, Clinical and experimental hypertension. Part A, Theory and practice.

[34]  M. Safar,et al.  Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. , 1988, Circulation research.

[35]  A. Lever.  Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? , 1986, Journal of hypertension.

[36]  B. Folkow.  Physiological aspects of primary hypertension. , 1982, Physiological reviews.

[37]  M. Mulvany,et al.  Direct Evidence that the Greater Contractility of Resistance Vessels in Spontaneously Hypertensive Rats is Associated with a Narrowed Lumen, a Thickened Media, and an Increased Number of Smooth Muscle Cell Layers , 1978, Circulation research.